WHATA briefing featuring key data presented at the 4th International Symposium on Focused Ultrasound, the world's leading forum dedicated to the latest clinical and translational developments in this non-invasive therapy. Global experts will highlight advances in the use of focused ultrasound to treat brain disorders and cancers as well as share promising data on several emerging applications.
WHENTuesday, October 14, 2014 • Lunch: 11:30am EDT • Presentations, Q&A and Webcast: 12:00 – 1:15pm EDT • Opportunities for one-on-one meetings with speakers: 1:15 - 1:40pm EDT
WHEREBethesda North Marriott Hotel & Conference Center5701 Marinelli Rd, Bethesda, MarylandTo attend the event in-person, contact Nicole Cohen at [email protected] or 202-729-4217
Click here to register for a live webcast of this event.
FEATURED SPEAKERS AND TOPICS
Dr. Andrew von Eschenbach, Former Commissioner of the Food and Drug Administration and Former Director of the National Cancer Institute • Will discuss the ongoing need for innovation and the potential of new technologies like focused ultrasound to meet the medical challenges of today and the future
Dr. Neal F. Kassell, Neurosurgeon, Chairman, Focused Ultrasound Foundation • Will review promising clinical research on the use of the technology to non-invasively treat the brain, including essential tremor, Parkinson’s disease, tumors and psychiatric disorders
Dr. Mark Hurwitz, Director of Thermal Oncology of the Department of Radiation Oncology, Thomas Jefferson University and Hospital • Will share data demonstrating the potential of focused ultrasound as a new oncology tool to treat cancers, including prostate, pancreas, breast, liver and soft tissue
Dr. Alessandro Napoli, Department of Radiological, Oncological & Pathological Sciences, Sapienza University of Rome • Will present on focused ultrasound for bone metastases and other painful adult and pediatric diseases as well as the pioneering use of the technology for conditions like hypertension
ABOUT FOCUSED ULTRASOUND TECHNOLOGY
Focused ultrasound is a revolutionary, early-stage therapeutic technology with the potential to transform the treatment of many serious medical disorders. This breakthrough technology uses ultrasonic energy guided by magnetic resonance or ultrasound imaging to treat tissue deep in the body without incisions or radiation. Focused ultrasound is currently approved in the U.S. to treat uterine fibroids and bone metastases, and there are a growing number of clinical applications in various stages of research and development around the world, including Parkinson's disease, essential tremor, neuropathic pain, breast and prostate cancer, and brain tumors. For more information about the Focused Ultrasound Foundation, visit www.fusfoundation.org.
RSS